Dr Garfall completed a BA in Molecular Biology at Princeton University, Princeton, NJ, in 2002 and went on to receive his medical degree from New York University School of Medicine, New York City, NY, in 2008. Dr Garfall then completed a fellowship at Memorial Sloan Kettering Cancer Center, New York City, NY, in 2008 followed by an internship and residency in internal medicine at Brigham and Women’s Hospital, Boston, MA, in 2009 and 2011 respectively. Dr Garfall also completed a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, Philadelphia, PA, in 2014.
Dr Garfall is currently an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, where he has served since 2015. Dr Garfall is part of the Penn Medicine programs and centers which provide care for patients with amyloidosis, bone marrow transplants, multiple myelomas and more.
Speaking on immunotherapies for hematological malignancies
Dr Garfall currently specializes in immunotherapies for hematological malignancies, with a particular focus on chimeric antigen receptor (CAR) T-cell therapies for multiple myeloma. Dr Garfall has been involved in a number of cutting-edge trials of CAR T-cell therapies, many of which are still ongoing.